Loading...

REGN REGENERON PHARMACEUTICALS INC Management Changes 8-K Filing

RGNR

RGN

REGENERON PHARMACEUTICALS INC

(REGN)

2023 8-K

Show Summary

Summary

Financial Statements

Financial Results

Financial Update

Q3 Earnings Report

Q3 2024 Preview

Earnings Reports

Financial Results

Shareholder Vote Results

Financial Results

Financial Results Announcement

Management Appointments

Corporate Update at Healthc...

Financial Results Announcement

Financial Results

Earnings Reports

Amendment to Bylaws and Sha...

Financial Results Announcement

Management Changes

Financial Results for Q1 2023

External Links:

Regeneron Pharmaceuticals, Inc. approved an amendment to its bylaws to implement a Board leadership succession plan, and shareholders voted on various proposals at the Annual Meeting.

AI Assistant

REGENERON PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.